Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 829 |
---|---|
Genomic Coordinate (GRCh38) | g.22077606_22077607del |
Variant | c.567_568del |
Variant Start Position | 567 |
Location | Exon 5 |
Amino Acid Change | p.Gln189Hisfs*22 |
ACMG Call | - |
ACMG Call Last Revised Date | 4/28/2021 |
Predicted ACMG Call | Pathogenic | Effect Type | Frameshift |
Variant Type | Small deletion |
PMID | 29707405, 34806794 |
Article Count | 2 |
Times Observed | < 3 |
Clinical Phenotype | - |
ACMG Categories | pvs1, ps2, pm2, ppc |
ACMG Explanations | pvs1: This is a loss of function variant. pm2: chrX:22095722 ref:CAG alt:C was not found in gnomAD exomes or genomes. |
Variant in Clinvar | No |
ClinVar Classification | - |
Categories In Literature | ppc, ps2 |
No Contrary Evidence Found | TRUE |
ExAC Allele Frequency | - |
Thousand Genomes Allel Frequency | - |
Ontology Relations | - |
hg19 Mapping Failed | FALSE |
Literature Alleles | X-22095722-CAG-C |
GnomAD Alleles | - |
DBNSFP Alleles | - |
Other Alleles | - |
Note | nan |
Warnings | - |